Fruquintinib-induced renal-limited thrombotic microangiopathy: a case report
Abstract Background Fruquintinib is a highly selective inhibitor of vascular endothelial growth factor receptor (VEGFR). Currently, there are no reported cases of fruquintinib causing kidney-restrictive thrombotic microangiopathy (TMA) in the available Chinese and foreign literature. Case presentati...
| Автори: | , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
BMC
2024-05-01
|
| Серія: | BMC Nephrology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12882-024-03598-8 |